{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:40:04Z","timestamp":1793072404596,"version":"4.5.0"},"reference-count":255,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82270804"],"award-info":[{"award-number":["No.82270804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["No.2023AFB867"],"award-info":[{"award-number":["No.2023AFB867"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04514-y","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T15:46:22Z","timestamp":1781365582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanoparticle-based strategies targeting disulfidptosis, anoikis, and PANoptosis for enhanced cancer therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiaquan","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Habibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongke","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"4514_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"4514_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cdd.2014.137","volume":"22","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 2015;22:58\u201373.","journal-title":"Cell Death Differ"},{"key":"4514_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7:286.","journal-title":"Signal Transduct Target Ther"},{"key":"4514_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364.","journal-title":"Cell Res"},{"key":"4514_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","volume":"22","author":"K Hadian","year":"2023","unstructured":"Hadian K, Stockwell BR. The therapeutic potential of targeting regulated non-apoptotic cell death. Nat Rev Drug Discovery. 2023;22:723\u201342.","journal-title":"Nat Rev Drug Discovery"},{"key":"4514_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Reviews Clin Oncol. 2021;18:280\u201396.","journal-title":"Nat Reviews Clin Oncol"},{"key":"4514_CR7","doi-asserted-by":"publisher","first-page":"108010","DOI":"10.1016\/j.pharmthera.2021.108010","volume":"232","author":"S Christgen","year":"2022","unstructured":"Christgen S, Tweedell RE, Kanneganti T-D. Programming inflammatory cell death for therapy. Pharmacol Ther. 2022;232:108010.","journal-title":"Pharmacol Ther"},{"key":"4514_CR8","doi-asserted-by":"publisher","unstructured":"Gong L, Huang D, Shi Y, Liang Za, Bu H. Regulated cell death in cancer: from pathogenesis to treatment. Chin Med J (Engl). 2023;136(6):653\u2013665. https:\/\/doi.org\/10.1097\/CM9.0000000000002239","DOI":"10.1097\/CM9.0000000000002239"},{"key":"4514_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/imr.13279","volume":"321","author":"X Sun","year":"2024","unstructured":"Sun X, Yang Y, Meng X, Li J, Liu X, Liu H. PANoptosis: Mechanisms, biology, and role in disease. Immunol Rev. 2024;321:246\u201362.","journal-title":"Immunol Rev"},{"key":"4514_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174.","journal-title":"J Hematol Oncol"},{"key":"4514_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","volume":"9","author":"K H\u00e4nggi","year":"2023","unstructured":"H\u00e4nggi K, Ruffell B. Cell death, therapeutics, and the immune response in cancer. Trends Cancer. 2023;9:381\u201396.","journal-title":"Trends Cancer"},{"key":"4514_CR12","first-page":"2021","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wu S, Liu F, Ke D, Wang X, Pan D, Xu W, Zhou L, He W. An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma. Front Immunol. 2021;12:2021.","journal-title":"Front Immunol"},{"key":"4514_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Reviews Gastroenterol Hepatol. 2021;18:804\u201323.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"4514_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41420-022-01161-8","volume":"8","author":"H Wang","year":"2022","unstructured":"Wang H, Liu M, Zeng X, Zheng Y, Wang Y, Zhou Y. Cell death affecting the progression of gastric cancer. Cell Death Discov. 2022;8:377.","journal-title":"Cell Death Discov"},{"key":"4514_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol. 2023;25:404\u201314.","journal-title":"Nat Cell Biol"},{"key":"4514_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620.","journal-title":"Protein Cell"},{"key":"4514_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41420-022-01218-8","volume":"8","author":"D Gong","year":"2022","unstructured":"Gong D, Chen M, Wang Y, Shi J, Hou Y. Role of ferroptosis on tumor progression and immunotherapy. Cell Death Discov. 2022;8:427.","journal-title":"Cell Death Discov"},{"key":"4514_CR18","doi-asserted-by":"publisher","first-page":"101099","DOI":"10.1016\/j.drup.2024.101099","volume":"75","author":"Y Wang","year":"2024","unstructured":"Wang Y, Cheng S, Fleishman JS, Chen J, Tang H, Chen Z-S, Chen W, Ding M. Targeting anoikis resistance as a strategy for cancer therapy. Drug Resist Updates. 2024;75:101099.","journal-title":"Drug Resist Updates"},{"key":"4514_CR19","doi-asserted-by":"publisher","first-page":"113473","DOI":"10.1016\/j.jep.2020.113473","volume":"267","author":"Z-J Que","year":"2021","unstructured":"Que Z-J, Yang Y, Liu H-T, Shang-Guan W-J, Yu P, Zhu L-H, Li H-G, Liu H-M, Tian J-H. Jinfukang regulates integrin\/Src pathway and anoikis mediating circulating lung cancer cells migration. J Ethnopharmacol. 2021;267:113473.","journal-title":"J Ethnopharmacol"},{"key":"4514_CR20","doi-asserted-by":"crossref","unstructured":"Sun B, Hu C, Yang Z, Zhang X, Zhao L, Xiong J, Ma J, Chen L, Qian H, Luo X et al. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells. Oncotarget; Vol 8, No 20 2017.","DOI":"10.18632\/oncotarget.15808"},{"key":"4514_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2017.11.025","volume":"69","author":"L Jin","year":"2018","unstructured":"Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha Y, Li D, Alesi GN, Kang Y, Zhou L, et al. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer. Mol Cell. 2018;69:87\u2013e9987.","journal-title":"Mol Cell"},{"key":"4514_CR22","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1038\/onc.2015.12","volume":"34","author":"D Malin","year":"2015","unstructured":"Malin D, Strekalova E, Petrovic V, Rajanala H, Sharma B, Ugolkov A, Gradishar WJ, Cryns VL. ERK-regulated \u03b1B-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo. Oncogene. 2015;34:5626\u201334.","journal-title":"Oncogene"},{"key":"4514_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","volume":"12","author":"AP Gilmore","year":"2005","unstructured":"Gilmore AP. Anoikis. Cell Death Differ. 2005;12:1473\u20137.","journal-title":"Cell Death Differ"},{"key":"4514_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41418-021-00855-3","volume":"29","author":"Z Zhi","year":"2022","unstructured":"Zhi Z, Ouyang Z, Ren Y, Cheng Y, Liu P, Wen Y, Shao Y. Non-canonical phosphorylation of Bmf by p38 MAPK promotes its apoptotic activity in anoikis. Cell Death Differ. 2022;29:323\u201336.","journal-title":"Cell Death Differ"},{"key":"4514_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.yexcr.2013.11.011","volume":"320","author":"L Carduner","year":"2014","unstructured":"Carduner L, Picot CR, Leroy-Dudal J, Blay L, Kellouche S, Carreiras F. Cell cycle arrest or survival signaling through \u03b1v integrins, activation of PKC and ERK1\/2 lead to anoikis resistance of ovarian cancer spheroids. Exp Cell Res. 2014;320:329\u201342.","journal-title":"Exp Cell Res"},{"key":"4514_CR26","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41416-022-01747-0","volume":"126","author":"Y Li","year":"2022","unstructured":"Li Y, Liu C, Zhang X, Huang X, Liang S, Xing F, Tian H. CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt\/\u03b2-catenin signalling pathway. Br J Cancer. 2022;126:1684\u201394.","journal-title":"Br J Cancer"},{"key":"4514_CR27","doi-asserted-by":"publisher","first-page":"111066","DOI":"10.1016\/j.celrep.2022.111066","volume":"40","author":"Z Shonibare","year":"2022","unstructured":"Shonibare Z, Monavarian M, O\u2019Connell K, Altomare D, Shelton A, Mehta S, Jaskula-Sztul R, Phaeton R, Starr MD, Whitaker R, et al. Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. Cell Rep. 2022;40:111066.","journal-title":"Cell Rep"},{"key":"4514_CR28","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-15-0411","volume":"21","author":"A Sebio","year":"2015","unstructured":"Sebio A, Lenz H-J. Molecular pathways: Hippo Signaling, a critical tumor suppressor. Clin Cancer Res. 2015;21:5002\u20137.","journal-title":"Clin Cancer Res"},{"key":"4514_CR29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The Biology of YAP\/TAZ: Hippo Signaling and Beyond. Physiol Rev. 2014;94:1287\u2013312.","journal-title":"Physiol Rev"},{"key":"4514_CR30","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1016\/j.bbagen.2013.03.009","volume":"1830","author":"L Wei","year":"2013","unstructured":"Wei L, Dai Q, Zhou Y, Zou M, Li Z, Lu N, Guo Q. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II. Biochim et Biophys Acta (BBA) - Gen Subj. 2013;1830:3835\u201345.","journal-title":"Biochim et Biophys Acta (BBA) - Gen Subj"},{"key":"4514_CR31","doi-asserted-by":"publisher","first-page":"e03255","DOI":"10.1016\/j.heliyon.2020.e03255","volume":"6","author":"TT San","year":"2020","unstructured":"San TT, Khaenam P, Prachayasittikul V, Sripa B, Kunkeaw N. Chan-on W: Curcumin enhances chemotherapeutic effects and suppresses ANGPTL4 in anoikis-resistant cholangiocarcinoma cells. Heliyon. 2020;6:e03255.","journal-title":"Heliyon"},{"key":"4514_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/labinvest.2011.187","volume":"92","author":"Y Sakuma","year":"2012","unstructured":"Sakuma Y, Yamazaki Y, Nakamura Y, Yoshihara M, Matsukuma S, Nakayama H, Yokose T, Kameda Y, Koizume S, Miyagi Y. WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors. Lab Invest. 2012;92:371\u201383.","journal-title":"Lab Invest"},{"key":"4514_CR33","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1038\/s41598-017-04147-0","volume":"7","author":"M Momeny","year":"2017","unstructured":"Momeny M, Zarrinrad G, Moghaddaskho F, Poursheikhani A, Sankanian G, Zaghal A, Mirshahvaladi S, Esmaeili F, Eyvani H, Barghi F, et al. Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells. Sci Rep. 2017;7:4204.","journal-title":"Sci Rep"},{"key":"4514_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41389-020-00247-1","volume":"9","author":"CJ Pierce","year":"2020","unstructured":"Pierce CJ, Simmons JL, Broit N, Karunarathne D, Ng MF, Boyle GM. BRN2 expression increases anoikis resistance in melanoma. Oncogenesis. 2020;9:64.","journal-title":"Oncogenesis"},{"key":"4514_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biomaterials.2015.07.012","volume":"67","author":"KP Hong","year":"2015","unstructured":"Hong KP, Shin MH, Yoon S, Ji GY, Moon YR, Lee O-J, Choi S-Y, Lee Y-M, Koo JH, Lee H-C, et al. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity. Biomaterials. 2015;67:32\u201341.","journal-title":"Biomaterials"},{"key":"4514_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.trsl.2022.08.010","volume":"253","author":"M Bose","year":"2023","unstructured":"Bose M, Sanders A, De C, Zhou R, Lala P, Shwartz S, Mitra B, Brouwer C, Mukherjee P. Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer. Translational Res. 2023;253:41\u201356.","journal-title":"Translational Res"},{"key":"4514_CR37","first-page":"216","volume":"15","author":"H Zhao","year":"2023","unstructured":"Zhao H, Liu R, Wang L, Tang F, Chen W, Liu YN. Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity. Nanomicro Lett. 2023;15:216.","journal-title":"Nanomicro Lett"},{"key":"4514_CR38","doi-asserted-by":"publisher","first-page":"122876","DOI":"10.1016\/j.biomaterials.2024.122876","volume":"314","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ding L, Feng J, Lin Z, Yao H, You X, Zhang X, Sun W, Liu Y, Wang P. Mesoporous cerium oxide nanoenzyme for Efficacious impeding tumor and metastasis via Conferring resistance to anoikis. Biomaterials. 2025;314:122876.","journal-title":"Biomaterials"},{"key":"4514_CR39","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/MCB.06248-11","volume":"32","author":"S Kamarajugadda","year":"2012","unstructured":"Kamarajugadda S, Stemboroski L, Cai Q, Simpson NE, Nayak S, Tan M, Lu J. Glucose oxidation modulates anoikis and tumor metastasis. Mol Cell Biol. 2012;32:1893\u2013907.","journal-title":"Mol Cell Biol"},{"key":"4514_CR40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7150\/thno.91814","volume":"14","author":"DKW Ocansey","year":"2024","unstructured":"Ocansey DKW, Qian F, Cai P, Ocansey S, Amoah S, Qian Y, Mao F. Current evidence and therapeutic implication of PANoptosis in cancer. Theranostics. 2024;14:640\u201361.","journal-title":"Theranostics"},{"key":"4514_CR41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-023-06370-2","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z, Jiang X, Wu F, He G. Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis. 2023;14:851.","journal-title":"Cell Death Dis"},{"key":"4514_CR42","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.33698","volume":"149","author":"M Jiang","year":"2021","unstructured":"Jiang M, Qi L, Li L, Wu Y, Song D, Li Y. Caspase-8: a key protein of cross-talk signal way in PANoptosis in cancer. Int J Cancer. 2021;149:1408\u201320.","journal-title":"Int J Cancer"},{"key":"4514_CR43","doi-asserted-by":"publisher","first-page":"109019","DOI":"10.1016\/j.clim.2022.109019","volume":"238","author":"H Pan","year":"2022","unstructured":"Pan H, Pan J, Li P, Gao J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clin Immunol. 2022;238:109019.","journal-title":"Clin Immunol"},{"key":"4514_CR44","doi-asserted-by":"publisher","unstructured":"Wang X, Sun R, Chan S, Meng L, Xu Y, Zuo X, Wang Z, Hu X, Han Q, Dai L et al. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer. Front Genet. 2022;13:955355. https:\/\/doi.org\/10.3389\/fgene.2022.955355","DOI":"10.3389\/fgene.2022.955355"},{"key":"4514_CR45","doi-asserted-by":"publisher","unstructured":"Song F, Wang C-G, Mao J-Z, Wang T-L, Liang X-L, Hu C-W, Zhang Y, Han L, Chen Z. PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma. Front Immunol. 2023;14:1197152. https:\/\/doi.org\/10.3389\/fimmu.2023.1197152","DOI":"10.3389\/fimmu.2023.1197152"},{"key":"4514_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20\u201337.","journal-title":"Nat Rev Cancer"},{"key":"4514_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","volume":"93","author":"E P\u00e9rez-Herrero","year":"2015","unstructured":"P\u00e9rez-Herrero E, Fern\u00e1ndez-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52\u201379.","journal-title":"Eur J Pharm Biopharm"},{"key":"4514_CR48","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1039\/D2RA07863E","volume":"13","author":"MJ Nirmala","year":"2023","unstructured":"Nirmala MJ, Kizhuveetil U, Johnson A, Nagarajan GB, Muthuvijayan R. Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv. 2023;13:8606\u201329.","journal-title":"RSC Adv"},{"key":"4514_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8:293.","journal-title":"Signal Transduct Target Ther"},{"key":"4514_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","volume":"14","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021;14:85.","journal-title":"J Hematol Oncol"},{"key":"4514_CR51","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","volume":"39","author":"M-r Liu","year":"2021","unstructured":"Liu M-r, Zhu W-t. Pei D-s: System Xc\u2013: a key regulatory target of ferroptosis in cancer. Investig New Drugs. 2021;39:1123\u201331.","journal-title":"Investig New Drugs"},{"key":"4514_CR52","doi-asserted-by":"publisher","unstructured":"Jiang Y, Sun M. SLC7A11: the Achilles heel of tumor? Front Immunol. 2024;15:1438807. https:\/\/doi.org\/10.3389\/fimmu.2024","DOI":"10.3389\/fimmu.2024"},{"key":"4514_CR53","first-page":"3106","volume":"10","author":"W Lin","year":"2020","unstructured":"Lin W, Wang C, Liu G, Bi C, Wang X, Zhou Q, Jin H. SLC7A11\/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020;10:3106\u201326.","journal-title":"Am J Cancer Res"},{"key":"4514_CR54","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10495-024-01989-8","volume":"29","author":"F Xiao","year":"2024","unstructured":"Xiao F, Li H-L, Yang B, Che H, Xu F, Li G, Zhou C-H, Wang S. Disulfidptosis: A new type of cell death. Apoptosis. 2024;29:1309\u201329.","journal-title":"Apoptosis"},{"key":"4514_CR55","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, Zhang J, Lee H, Koppula P, Lei G, et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020;22:476\u201386.","journal-title":"Nat Cell Biol"},{"key":"4514_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40364-024-00593-x","volume":"12","author":"J Chen","year":"2024","unstructured":"Chen J, Ma B, Yang Y, Wang B, Hao J, Zhou X. Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions. Biomark Res. 2024;12:45.","journal-title":"Biomark Res"},{"key":"4514_CR57","doi-asserted-by":"crossref","unstructured":"Ma N, Xu E, Luo Q, Song G. Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. In Molecules, vol. 28; 2023.","DOI":"10.3390\/molecules28072976"},{"key":"4514_CR58","doi-asserted-by":"publisher","first-page":"115180","DOI":"10.1016\/j.bcp.2022.115180","volume":"203","author":"C Bailly","year":"2022","unstructured":"Bailly C, Beignet J, Loirand G, Sauzeau V. Rac1 as a therapeutic anticancer target: Promises and limitations. Biochem Pharmacol. 2022;203:115180.","journal-title":"Biochem Pharmacol"},{"key":"4514_CR59","doi-asserted-by":"publisher","unstructured":"Liang J, Oyang L, Rao S, Han Y, Luo X, Yi P, Lin J, Xia L, Hu J, Tan S et al. Rac1, A Potential Target for Tumor Therapy. Front Oncol. 2021;11:674426. https:\/\/doi.org\/10.3389\/fonc.2021.674426","DOI":"10.3389\/fonc.2021.674426"},{"key":"4514_CR60","doi-asserted-by":"crossref","unstructured":"Rana PS, Alkrekshi A, Wang W, Markovic V, Sossey-Alaoui K. The Role of WAVE2 Signaling in Cancer. In Biomedicines, vol. 9; 2021.","DOI":"10.3390\/biomedicines9091217"},{"key":"4514_CR61","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s12276-023-01004-1","volume":"55","author":"KA Han","year":"2023","unstructured":"Han KA, Ko J. Orchestration of synaptic functions by WAVE regulatory complex-mediated actin reorganization. Exp Mol Med. 2023;55:1065\u201375.","journal-title":"Exp Mol Med"},{"key":"4514_CR62","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12964-024-01871-9","volume":"22","author":"T Li","year":"2024","unstructured":"Li T, Song Y, Wei L, Song X, Duan R. Disulfidptosis: a novel cell death modality induced by actin cytoskeleton collapse and a promising target for cancer therapeutics. Cell Communication Signal. 2024;22:491.","journal-title":"Cell Communication Signal"},{"key":"4514_CR63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1242\/jcs.00233","volume":"116","author":"M Nozumi","year":"2003","unstructured":"Nozumi M, Nakagawa H, Miki H, Takenawa T, Miyamoto S. Differential localization of WAVE isoforms in filopodia and lamellipodia of the neuronal growth cone. J Cell Sci. 2003;116:239\u201346.","journal-title":"J Cell Sci"},{"key":"4514_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tcb.2016.08.001","volume":"27","author":"J Pizarro-Cerd\u00e1","year":"2017","unstructured":"Pizarro-Cerd\u00e1 J, Chorev DS, Geiger B, Cossart P. The diverse family of Arp2\/3 complexes. Trends Cell Biol. 2017;27:93\u2013100.","journal-title":"Trends Cell Biol"},{"key":"4514_CR65","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1152\/physrev.00006.2017","volume":"98","author":"N Molinie","year":"2017","unstructured":"Molinie N, Gautreau A. The Arp2\/3 Regulatory System and Its Deregulation in Cancer. Physiol Rev. 2017;98:215\u201338.","journal-title":"Physiol Rev"},{"key":"4514_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nsmb870","volume":"12","author":"AA Rodal","year":"2005","unstructured":"Rodal AA, Sokolova O, Robins DB, Daugherty KM, Hippenmeyer S, Riezman H, Grigorieff N, Goode BL. Conformational changes in the Arp2\/3 complex leading to actin nucleation. Nat Struct Mol Biol. 2005;12:26\u201331.","journal-title":"Nat Struct Mol Biol"},{"key":"4514_CR67","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1038\/s41467-022-33174-3","volume":"13","author":"B Ding","year":"2022","unstructured":"Ding B, Yang S, Schaks M, Liu Y, Brown AJ, Rottner K, Chowdhury S, Chen B. Structures reveal a key mechanism of WAVE regulatory complex activation by Rac1 GTPase. Nat Commun. 2022;13:5444.","journal-title":"Nat Commun"},{"key":"4514_CR68","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/gb-2009-10-6-226","volume":"10","author":"S Kurisu","year":"2009","unstructured":"Kurisu S, Takenawa T. The WASP and WAVE family proteins. Genome Biol. 2009;10:226.","journal-title":"Genome Biol"},{"key":"4514_CR69","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nsmb.1587","volume":"16","author":"AM Ismail","year":"2009","unstructured":"Ismail AM, Padrick SB, Chen B, Umetani J, Rosen MK. The WAVE regulatory complex is inhibited. Nat Struct Mol Biol. 2009;16:561\u20133.","journal-title":"Nat Struct Mol Biol"},{"key":"4514_CR70","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619\u201326.","journal-title":"J Cell Biol"},{"key":"4514_CR71","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1242\/jcs.072165","volume":"124","author":"MC Guadamillas","year":"2011","unstructured":"Guadamillas MC, Cerezo A, del Pozo MA. Overcoming anoikis \u2013 pathways to anchorage-independent growth in cancer. J Cell Sci. 2011;124:3189\u201397.","journal-title":"J Cell Sci"},{"key":"4514_CR72","doi-asserted-by":"publisher","first-page":"e22598","DOI":"10.1016\/j.heliyon.2023.e22598","volume":"9","author":"Z Sobhi Amjad","year":"2023","unstructured":"Sobhi Amjad Z, Shojaeian A, Sadri Nahand J, Bayat M, Taghizadieh M, Rostamian M, et al. Oncoviruses: induction of cancer development and metastasis by increasing anoikis resistance. Heliyon. 2023;9:e22598.","journal-title":"Heliyon"},{"key":"4514_CR73","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D\u2019Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8:603\u201319.","journal-title":"Aging"},{"key":"4514_CR74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12964-023-01247-5","volume":"21","author":"Y-H Han","year":"2023","unstructured":"Han Y-H, Wang Y, Lee S-J, Jin M-H, Sun H-N, Kwon T. Regulation of anoikis by extrinsic death receptor pathways. Cell Communication Signal. 2023;21:227.","journal-title":"Cell Communication Signal"},{"key":"4514_CR75","doi-asserted-by":"publisher","unstructured":"Adeshakin FO, Adeshakin AO, Afolabi LO, Yan D, Zhang G, Wan X. Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming. Front Oncol. 2021;11:626577. https:\/\/doi.org\/10.3389\/fonc.2021.626577","DOI":"10.3389\/fonc.2021.626577"},{"key":"4514_CR76","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcb.26363","volume":"119","author":"E Kakavandi","year":"2018","unstructured":"Kakavandi E, Shahbahrami R, Goudarzi H, Eslami G, Faghihloo E. Anoikis resistance and oncoviruses. J Cell Biochem. 2018;119:2484\u201391.","journal-title":"J Cell Biochem"},{"key":"4514_CR77","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12964-023-01183-4","volume":"21","author":"Y Dai","year":"2023","unstructured":"Dai Y, Zhang X, Ou Y, Zou L, Zhang D, Yang Q, Qin Y, Du X, Li W, Yuan Z, et al. Anoikis resistance\u2013\u2013protagonists of breast cancer cells survive and metastasize after ECM detachment. Cell Communication Signal. 2023;21:190.","journal-title":"Cell Communication Signal"},{"key":"4514_CR78","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tcb.2016.02.001","volume":"26","author":"J Alanko","year":"2016","unstructured":"Alanko J, Ivaska J. Endosomes: Emerging Platforms for Integrin-Mediated FAK Signalling. Trends Cell Biol. 2016;26:391\u20138.","journal-title":"Trends Cell Biol"},{"key":"4514_CR79","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/15384101.2015.1130576","volume":"15","author":"J Alanko","year":"2016","unstructured":"Alanko J, Ivaska J. Integrin endoadhesome signaling suppresses anoikis. Cell Cycle. 2016;15:605\u20136.","journal-title":"Cell Cycle"},{"key":"4514_CR80","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nrd3266","volume":"9","author":"D Cox","year":"2010","unstructured":"Cox D, Brennan M, Moran N. Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discovery. 2010;9:804\u201320.","journal-title":"Nat Rev Drug Discovery"},{"key":"4514_CR81","doi-asserted-by":"publisher","first-page":"108458","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"Liu F, Wu Q, Dong Z, Liu K. Integrins in cancer: Emerging mechanisms and therapeutic opportunities. Pharmacol Ther. 2023;247:108458.","journal-title":"Pharmacol Ther"},{"key":"4514_CR82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.molmed.2023.10.001","volume":"30","author":"A Pandeya","year":"2024","unstructured":"Pandeya A, Kanneganti T-D. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes. Trends Mol Med. 2024;30:74\u201388.","journal-title":"Trends Mol Med"},{"key":"4514_CR83","doi-asserted-by":"publisher","unstructured":"Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, Place DE, Briard B, Sharma BR, Tuladhar S et al. Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:237. https:\/\/doi.org\/10.3389\/fcimb.2020.00237","DOI":"10.3389\/fcimb.2020.00237"},{"key":"4514_CR84","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.cell.2023.05.005","volume":"186","author":"B Sundaram","year":"2023","unstructured":"Sundaram B, Pandian N, Mall R, Wang Y, Sarkar R, Kim HJ, Malireddi RKS, Karki R, Janke LJ, Vogel P, Kanneganti T-D. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell. 2023;186:2783\u2013e28012720.","journal-title":"Cell"},{"key":"4514_CR85","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti T-D. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021;597:415\u20139.","journal-title":"Nature"},{"key":"4514_CR86","doi-asserted-by":"crossref","unstructured":"Malireddi RKS, Kesavardhana S, Kanneganti T-D. ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome\/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:2019.","DOI":"10.3389\/fcimb.2019.00406"},{"key":"4514_CR87","doi-asserted-by":"publisher","first-page":"2250235","DOI":"10.1002\/eji.202250235","volume":"53","author":"W Chen","year":"2023","unstructured":"Chen W, Gullett JM, Tweedell RE, Kanneganti T-D. Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease. Eur J Immunol. 2023;53:2250235.","journal-title":"Eur J Immunol"},{"key":"4514_CR88","doi-asserted-by":"publisher","first-page":"e20191644","DOI":"10.1084\/jem.20191644","volume":"217","author":"RKS Malireddi","year":"2019","unstructured":"Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, Vogel P, Pelletier S, Burgula S, Kanneganti T-D. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity\u2013independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2019;217:e20191644.","journal-title":"J Exp Med"},{"key":"4514_CR89","doi-asserted-by":"publisher","unstructured":"Samir P, Malireddi RKS, Kanneganti T-D. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:238. https:\/\/doi.org\/10.3389\/fcimb.2020.00238","DOI":"10.3389\/fcimb.2020.00238"},{"key":"4514_CR90","doi-asserted-by":"publisher","unstructured":"Zhu P, Ke Z-R, Chen J-X, Li S-J, Ma T-L, Fan X-L. Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment. Front Immunol. 2023;14:1120034. https:\/\/doi.org\/10.3389\/fimmu.2023","DOI":"10.3389\/fimmu.2023"},{"key":"4514_CR91","doi-asserted-by":"publisher","unstructured":"Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, Vogel P, Pelletier S, Burgula S, Kanneganti TD. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2020;217(3):jem.20191644. https:\/\/doi.org\/10.1084\/jem.20191644","DOI":"10.1084\/jem.20191644"},{"key":"4514_CR92","doi-asserted-by":"publisher","unstructured":"Hao Y, Yang B, Yang J, Shi X, Yang X, Zhang D, Zhao D, Yan W, Chen L, Zheng H et al. ZBP1: A Powerful Innate Immune Sensor and Double-Edged Sword in Host Immunity. Int J Mol Sci. 2022;23(18):10224. https:\/\/doi.org\/10.3390\/ijms231810224","DOI":"10.3390\/ijms231810224"},{"key":"4514_CR93","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.coviro.2021.10.004","volume":"51","author":"S Balachandran","year":"2021","unstructured":"Balachandran S, Mocarski ES. Viral Z-RNA triggers ZBP1-dependent cell death. Curr Opin Virol. 2021;51:134\u201340.","journal-title":"Curr Opin Virol"},{"key":"4514_CR94","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1126\/science.abg5251","volume":"376","author":"F Yuan","year":"2022","unstructured":"Yuan F, Cai J, Wu J, Tang Y, Zhao K, Liang F, Li F, Yang X, He Z, Billiar TR, et al. Z-DNA binding protein 1 promotes heatstroke-induced cell death. Science. 2022;376:609\u201315.","journal-title":"Science"},{"key":"4514_CR95","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1042\/BST20220535","volume":"50","author":"T Riebeling","year":"2022","unstructured":"Riebeling T, Kunzendorf U, Krautwald S. The role of RHIM in necroptosis. Biochem Soc Trans. 2022;50:1197\u2013205.","journal-title":"Biochem Soc Trans"},{"key":"4514_CR96","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cell.2020.03.040","volume":"181","author":"M Zheng","year":"2020","unstructured":"Zheng M, Karki R, Vogel P, Kanneganti T-D. Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense. Cell. 2020;181:674\u2013e687613.","journal-title":"Cell"},{"key":"4514_CR97","doi-asserted-by":"crossref","unstructured":"Kuriakose T, Man SM, Subbarao Malireddi RK, Karki R, Kesavardhana S, Place DE, Neale G, Vogel P, Kanneganti T-D. ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Science Immunology 2016, 1:aag2045-aag2045.","DOI":"10.1126\/sciimmunol.aag2045"},{"key":"4514_CR98","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.chom.2016.09.014","volume":"20","author":"RJ Thapa","year":"2016","unstructured":"Thapa RJ, Ingram JP, Ragan KB, Nogusa S, Boyd DF, Benitez AA, Sridharan H, Kosoff R, Shubina M, Landsteiner VJ, et al. DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. Cell Host Microbe. 2016;20:674\u201381.","journal-title":"Cell Host Microbe"},{"key":"4514_CR99","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ni.3015","volume":"15","author":"X Wang","year":"2014","unstructured":"Wang X, Jiang W, Yan Y, Gong T, Han J, Tian Z, Zhou R. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat Immunol. 2014;15:1126\u201333.","journal-title":"Nat Immunol"},{"key":"4514_CR100","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mib.2020.07.012","volume":"59","author":"DE Place","year":"2021","unstructured":"Place DE, Lee S, Kanneganti T-D. PANoptosis in microbial infection. Curr Opin Microbiol. 2021;59:42\u20139.","journal-title":"Curr Opin Microbiol"},{"key":"4514_CR101","doi-asserted-by":"publisher","first-page":"e20210273","DOI":"10.1084\/jem.20210273","volume":"218","author":"J Zhao","year":"2021","unstructured":"Zhao J, Miller-Little W, Li X. Inflammasome-independent functions of AIM2. J Exp Med. 2021;218:e20210273.","journal-title":"J Exp Med"},{"key":"4514_CR102","doi-asserted-by":"publisher","first-page":"122158","DOI":"10.1016\/j.lfs.2023.122158","volume":"333","author":"Z Qi","year":"2023","unstructured":"Qi Z, Zhu L, Wang K, Wang N. PANoptosis: Emerging mechanisms and disease implications. Life Sci. 2023;333:122158.","journal-title":"Life Sci"},{"key":"4514_CR103","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.4049\/jimmunol.1800788","volume":"201","author":"Q Zhu","year":"2018","unstructured":"Zhu Q, Zheng M, Balakrishnan A, Karki R, Kanneganti TD. Gasdermin D Promotes AIM2 Inflammasome Activation and Is Required for Host Protection against Francisella novicida. J Immunol. 2018;201:3662\u20138.","journal-title":"J Immunol"},{"key":"4514_CR104","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054\u201381.","journal-title":"Autophagy"},{"key":"4514_CR105","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/procel\/pwae003","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao C, Wang M, Zhuang L, Gan B. Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond. Protein Cell. 2024;15:642\u201360.","journal-title":"Protein Cell"},{"key":"4514_CR106","doi-asserted-by":"publisher","unstructured":"Liz\u00e1k B, Szarka A, Kim Y, Choi K-s, N\u00e9meth CE, Marcolongo P, Benedetti A, B\u00e1nhegyi G, Margittai \u00c9. Glucose Transport and Transporters in the Endomembranes. Int J Mol Sci. 2019;20(23):5898. https:\/\/doi.org\/10.3390\/ijms20235898","DOI":"10.3390\/ijms20235898"},{"key":"4514_CR107","doi-asserted-by":"publisher","first-page":"116643","DOI":"10.1016\/j.biopha.2024.116643","volume":"175","author":"M Huang","year":"2024","unstructured":"Huang M, Liu M, Wang R, Man Y, Zhou H, Xu Z-X, Wang Y. The crosstalk between glucose metabolism and telomerase regulation in cancer. Biomed Pharmacother. 2024;175:116643.","journal-title":"Biomed Pharmacother"},{"key":"4514_CR108","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.7150\/ijbs.104598","volume":"21","author":"Y Yin","year":"2025","unstructured":"Yin Y, Sun Y, Yao H, Yu F, Jia Q, Hu C, Zhu Y, Duan Z, Liu D, Sun Y, et al. TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the \u03b2-catenin-c-MYC-GLUT1 axis. Int J Biol Sci. 2025;21:1932\u201348.","journal-title":"Int J Biol Sci"},{"key":"4514_CR109","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstr\u00e5le M, Laurila E, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"4514_CR110","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41556-025-01673-2","volume":"27","author":"J Wan","year":"2025","unstructured":"Wan J, Shi J-H, Shi M, Huang H, Zhang Z, Li W, Guo C, Bao R, Yu X, Han Q, et al. Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8\u2009+\u2009T cells. Nat Cell Biol. 2025;27:972\u201382.","journal-title":"Nat Cell Biol"},{"key":"4514_CR111","doi-asserted-by":"publisher","first-page":"2501780","DOI":"10.1080\/15384047.2025.2501780","volume":"26","author":"C Zeng","year":"2025","unstructured":"Zeng C, Huang D, Wang L, Liang H, Ma X. Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells. Cancer Biol Ther. 2025;26:2501780.","journal-title":"Cancer Biol Ther"},{"key":"4514_CR112","doi-asserted-by":"publisher","unstructured":"Li G, Li Q, Yang S, Guo D, Tao Y, Jia Y. FGA modulates immune infiltration and tumor progression via SLC7A11\/xCT-mediated disulfidptosis in the tumor microenvironment of lung adenocarcinoma. Front Immunol. 2025;16:1595900. https:\/\/doi.org\/10.3389\/fimmu.2025.1595900","DOI":"10.3389\/fimmu.2025.1595900"},{"key":"4514_CR113","doi-asserted-by":"publisher","first-page":"102966","DOI":"10.1016\/j.redox.2023.102966","volume":"68","author":"D Zhao","year":"2023","unstructured":"Zhao D, Meng Y, Dian Y, Zhou Q, Sun Y, Le J, Zeng F, Chen X, He Y, Deng G. Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy. Redox Biol. 2023;68:102966.","journal-title":"Redox Biol"},{"key":"4514_CR114","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.tranon.2024.102091","volume":"49","author":"K Zhang","year":"2024","unstructured":"Zhang K, Zhu Z, Zhou J, Shi M, Wang N, Yu F, Xu L. Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance. Translational Oncol. 2024;49:102091.","journal-title":"Translational Oncol"},{"key":"4514_CR115","doi-asserted-by":"publisher","first-page":"217750","DOI":"10.1016\/j.canlet.2025.217750","volume":"624","author":"P Shaw","year":"2025","unstructured":"Shaw P, Dey Bhowmik A, Gopinatha Pillai MS, Robbins N, Dwivedi SKD, Rao G. Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding. Cancer Lett. 2025;624:217750.","journal-title":"Cancer Lett"},{"key":"4514_CR116","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s10555-024-10178-7","volume":"43","author":"S Zhou","year":"2024","unstructured":"Zhou S, Xu H, Duan Y, Tang Q, Huang H, Bi F. Survival mechanisms of circulating tumor cells and their implications for cancer treatment. Cancer Metastasis Rev. 2024;43:941\u201357.","journal-title":"Cancer Metastasis Rev"},{"key":"4514_CR117","doi-asserted-by":"publisher","first-page":"14535","DOI":"10.1038\/s41598-025-98661-1","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu X, Liu Y, Hu Y, Su F, Wang Z, Chen Y, Zhuang Z. Leucine rich repeat containing 15 promotes triple-negative breast cancer proliferation and invasion via the ITGB1\/FAK\/PI3K signalling pathway. Sci Rep. 2025;15:14535.","journal-title":"Sci Rep"},{"key":"4514_CR118","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1158\/0008-5472.CAN-21-3734","volume":"82","author":"U Ray","year":"2022","unstructured":"Ray U, Pathoulas CL, Thirusangu P, Purcell JW, Kannan N, Shridhar V. Exploiting LRRC15 as a Novel Therapeutic Target in Cancer. Cancer Res. 2022;82:1675\u201381.","journal-title":"Cancer Res"},{"key":"4514_CR119","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1158\/0008-5472.CAN-21-0622","volume":"82","author":"U Ray","year":"2022","unstructured":"Ray U, Jung DB, Jin L, Xiao Y, Dasari S, Sarkar Bhattacharya S, Thirusangu P, Staub JK, Roy D, Roy B, et al. Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer. Cancer Res. 2022;82:1038\u201354.","journal-title":"Cancer Res"},{"key":"4514_CR120","doi-asserted-by":"publisher","first-page":"39867","DOI":"10.1074\/jbc.M007040200","volume":"275","author":"E Borges","year":"2000","unstructured":"Borges E, Jan Y, Ruoslahti E. Platelet-derived Growth Factor Receptor \u03b2 and Vascular Endothelial Growth Factor Receptor 2 Bind to the \u03b23Integrin through Its Extracellular Domain*. J Biol Chem. 2000;275:39867\u201373.","journal-title":"J Biol Chem"},{"key":"4514_CR121","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10495-019-01573-5","volume":"24","author":"D Guha","year":"2019","unstructured":"Guha D, Saha T, Bose S, Chakraborty S, Dhar S, Khan P, Adhikary A, Das T, Sa G. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells. Apoptosis. 2019;24:958\u201371.","journal-title":"Apoptosis"},{"key":"4514_CR122","doi-asserted-by":"publisher","first-page":"155714","DOI":"10.1016\/j.phymed.2024.155714","volume":"129","author":"Y Zou","year":"2024","unstructured":"Zou Y, Xu L, Wang W, Zhu X, Lin J, Li H, Chen J, Xu W, Gao H, Wu X, et al. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR\/Integrin \u03b21\/FAK signaling pathway. Phytomedicine. 2024;129:155714.","journal-title":"Phytomedicine"},{"key":"4514_CR123","doi-asserted-by":"publisher","first-page":"116678","DOI":"10.1016\/j.ejmech.2024.116678","volume":"276","author":"X Wang","year":"2024","unstructured":"Wang X, Li N, Liu Y-H, Wu J, Liu Q-G, Niu J-B, Xu Y, Huang C-Z, Zhang S-Y, Song J. Targeting focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders. Eur J Med Chem. 2024;276:116678.","journal-title":"Eur J Med Chem"},{"key":"4514_CR124","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1101\/gad.277681.116","volume":"30","author":"T Celi\u00e0-Terrassa","year":"2016","unstructured":"Celi\u00e0-Terrassa T, Kang Y. Distinctive properties of metastasis-initiating cells. Genes Dev. 2016;30:892\u2013908.","journal-title":"Genes Dev"},{"key":"4514_CR125","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1074\/jbc.M115.704254","volume":"291","author":"LR de la Ballina","year":"2016","unstructured":"de la Ballina LR, Cano-Crespo S, Gonz\u00e1lez-Mu\u00f1oz E, Bial S, Estrach S, Cailleteau L, Tissot F, Daniel H, Zorzano A, Ginsberg MH, et al. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability*. J Biol Chem. 2016;291:9700\u201311.","journal-title":"J Biol Chem"},{"key":"4514_CR126","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.freeradbiomed.2024.05.018","volume":"220","author":"LV Nalla","year":"2024","unstructured":"Nalla LV, Khairnar A. Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer. Free Radic Biol Med. 2024;220:288\u2013300.","journal-title":"Free Radic Biol Med"},{"key":"4514_CR127","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu VS, O\u2019Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis Marcia C, de Carvalho FM, Damascena A, Domingos Chinen LT, Rocha RM, et al. PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 2014;16:992\u20131003.","journal-title":"Nat Cell Biol"},{"key":"4514_CR128","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13046-024-03101-z","volume":"43","author":"S Fan","year":"2024","unstructured":"Fan S, Yan X, Hu X, Liu X, Zhao S, Zhang Y, Zhou X, Shen X, Qi Q, Chen Y. Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK-3\u03b2\/NEDD4-1 mediated phosphorylation-dependent degradation of PGC-1\u03b1. J Experimental Clin Cancer Res. 2024;43:180.","journal-title":"J Experimental Clin Cancer Res"},{"key":"4514_CR129","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Chen C, Zhao C, Li T, Ma L, Jiang J, Duan Z, Si Q, Chuang T-H, Xiang R, Luo Y. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduct Target Therapy. 2024;9:64.","journal-title":"Signal Transduct Target Therapy"},{"key":"4514_CR130","doi-asserted-by":"publisher","first-page":"102544","DOI":"10.1016\/j.redox.2022.102544","volume":"58","author":"T Tian","year":"2022","unstructured":"Tian T, Lu Y, Lin J, Chen M, Qiu H, Zhu W, Sun H, Huang J, Yang H, Deng W. CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. Redox Biol. 2022;58:102544.","journal-title":"Redox Biol"},{"key":"4514_CR131","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s43018-024-00736-x","volume":"5","author":"H Dong","year":"2024","unstructured":"Dong H, He X, Zhang L, Chen W, Lin Y-C, Liu S-B, Wang H, Nguyen LXT, Li M, Zhu Y, et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024;5:601\u201324.","journal-title":"Nat Cancer"},{"key":"4514_CR132","doi-asserted-by":"publisher","first-page":"101461","DOI":"10.1016\/j.xcrm.2024.101461","volume":"5","author":"B Ku","year":"2024","unstructured":"Ku B, Eisenbarth D, Baek S, Jeong T-K, Kang J-G, Hwang D, Noh M-G, Choi C, Choi S, Seol T, et al. PRMT1 promotes pancreatic cancer development and resistance to chemotherapy. Cell Rep Med. 2024;5:101461.","journal-title":"Cell Rep Med"},{"key":"4514_CR133","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41419-024-06544-6","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu H, Chen X, Wang P, Chen M, Deng C, Qian X, Bai J, Li Z, Yu X. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis. Cell Death Dis. 2024;15:170.","journal-title":"Cell Death Dis"},{"key":"4514_CR134","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1038\/s41388-022-02387-7","volume":"41","author":"Q Meng","year":"2022","unstructured":"Meng Q, Lu Y-X, Wei C, Wang Z-X, Lin J-F, Liao K, Luo X-J, Yu K, Han Y, Li J-J, et al. Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasis. Oncogene. 2022;41:3912\u201324.","journal-title":"Oncogene"},{"key":"4514_CR135","doi-asserted-by":"publisher","first-page":"959521","DOI":"10.3389\/fcell.2022.959521","volume":"10","author":"R Qin","year":"2022","unstructured":"Qin R, Melamed S, Yang B, Saxena M, Sheetz MP, Wolfenson H. Tumor Suppressor DAPK1 Catalyzes Adhesion Assembly on Rigid but Anoikis on Soft Matrices. Front Cell Dev Biol. 2022;10:959521.","journal-title":"Front Cell Dev Biol"},{"key":"4514_CR136","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1002\/jcp.27149","volume":"234","author":"S Li","year":"2019","unstructured":"Li S, Chen Y, Zhang Y, Jiang X, Jiang Y, Qin X, Yang H, Wu C, Liu Y. Shear stress promotes anoikis resistance of cancer cells via caveolin-1-dependent extrinsic and intrinsic apoptotic pathways. J Cell Physiol. 2019;234:3730\u201343.","journal-title":"J Cell Physiol"},{"key":"4514_CR137","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-023-01753-7","volume":"22","author":"HD Huh","year":"2023","unstructured":"Huh HD, Sub Y, Oh J, Kim YE, Lee JY, Kim H-R, Lee S, Lee H, Pak S, Amos SE, et al. Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination. Mol Cancer. 2023;22:63.","journal-title":"Mol Cancer"},{"key":"4514_CR138","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13046-024-03089-6","volume":"43","author":"L Gao","year":"2024","unstructured":"Gao L, Shay C, Teng Y. Cell death shapes cancer immunity: spotlighting PANoptosis. J Experimental Clin Cancer Res. 2024;43:168.","journal-title":"J Experimental Clin Cancer Res"},{"key":"4514_CR139","doi-asserted-by":"publisher","unstructured":"Liu J, Hong M, Li Y, Chen D, Wu Y, Hu Y. Programmed Cell Death Tunes Tumor Immunity. Front Immunol. 2022;13:847345. https:\/\/doi.org\/10.3389\/fimmu.2022.847345","DOI":"10.3389\/fimmu.2022.847345"},{"key":"4514_CR140","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1038\/s41598-023-30934-z","volume":"13","author":"L Zhuang","year":"2023","unstructured":"Zhuang L, Sun Q, Huang S, Hu L, Chen Q. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer. Sci Rep. 2023;13:3877.","journal-title":"Sci Rep"},{"key":"4514_CR141","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4049\/immunohorizons.2100059","volume":"5","author":"RKS Malireddi","year":"2021","unstructured":"Malireddi RKS, Karki R, Sundaram B, Kancharana B, Lee S, Samir P, Kanneganti TD. Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth. Immunohorizons. 2021;5:568\u201380.","journal-title":"Immunohorizons"},{"key":"4514_CR142","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41392-022-00889-0","volume":"7","author":"J-F Lin","year":"2022","unstructured":"Lin J-F, Hu P-S, Wang Y-Y, Tan Y-T, Yu K, Liao K, Wu Q-N, Li T, Meng Q, Lin J-Z, et al. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduct Target Therapy. 2022;7:54.","journal-title":"Signal Transduct Target Therapy"},{"key":"4514_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2022.01.004","volume":"64","author":"H Zhou","year":"2022","unstructured":"Zhou H, Tang Y-D, Zheng C. Revisiting IRF1-mediated antiviral innate immunity. Cytokine Growth Factor Rev. 2022;64:1\u20136.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4514_CR144","doi-asserted-by":"publisher","unstructured":"Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P, Tuladhar S, Mummareddy H, Burton AR, Vogel P, Kanneganti TD. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. 2020;5(12):e136720. https:\/\/doi.org\/10.1172\/jci.insight.136720","DOI":"10.1172\/jci.insight.136720"},{"key":"4514_CR145","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ni.3118","volume":"16","author":"SM Man","year":"2015","unstructured":"Man SM, Karki R, Malireddi RKS, Neale G, Vogel P, Yamamoto M, Lamkanfi M, Kanneganti T-D. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol. 2015;16:467\u201375.","journal-title":"Nat Immunol"},{"key":"4514_CR146","doi-asserted-by":"publisher","first-page":"105141","DOI":"10.1016\/j.jbc.2023.105141","volume":"299","author":"BR Sharma","year":"2023","unstructured":"Sharma BR, Karki R, Rajesh Y, Kanneganti T-D. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis). J Biol Chem. 2023;299:105141.","journal-title":"J Biol Chem"},{"key":"4514_CR147","doi-asserted-by":"publisher","first-page":"109858","DOI":"10.1016\/j.celrep.2021.109858","volume":"37","author":"R Karki","year":"2021","unstructured":"Karki R, Sundaram B, Sharma BR, Lee S, Malireddi RKS, Nguyen LN, Christgen S, Zheng M, Wang Y, Samir P, et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 2021;37:109858.","journal-title":"Cell Rep"},{"key":"4514_CR148","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41594-020-0398-4","volume":"27","author":"Y Song","year":"2020","unstructured":"Song Y, Yang W, Fu Q, Wu L, Zhao X, Zhang Y, Zhang R. irCLASH reveals RNA substrates recognized by human ADARs. Nat Struct Mol Biol. 2020;27:351\u201362.","journal-title":"Nat Struct Mol Biol"},{"key":"4514_CR149","doi-asserted-by":"publisher","first-page":"109500","DOI":"10.1016\/j.celrep.2021.109500","volume":"36","author":"R de Reuver","year":"2021","unstructured":"de Reuver R, Dierick E, Wiernicki B, Staes K, Seys L, De Meester E, Muyldermans T, Botzki A, Lambrecht BN, Van Nieuwerburgh F, et al. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation. Cell Rep. 2021;36:109500.","journal-title":"Cell Rep"},{"key":"4514_CR150","doi-asserted-by":"crossref","unstructured":"Chen S, Bonifati S, Qin Z, St. Gelais C, Kodigepalli KM, Barrett BS, Kim SH, Antonucci JM, Ladner KJ, Buzovetsky O et al. SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-\u03baB and interferon pathways. Proceedings of the National Academy of Sciences 2018, 115:E3798-E3807.","DOI":"10.1073\/pnas.1801213115"},{"key":"4514_CR151","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.4049\/jimmunol.1401337","volume":"193","author":"J Ahn","year":"2014","unstructured":"Ahn J, Ruiz P, Barber GN. Intrinsic self-DNA triggers inflammatory disease dependent on STING. J Immunol. 2014;193:4634\u201342.","journal-title":"J Immunol"},{"key":"4514_CR152","doi-asserted-by":"crossref","unstructured":"Xu Y, Nowsheen S, Deng M. DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy. In Cancers, vol. 15; 2023.","DOI":"10.3390\/cancers15051619"},{"key":"4514_CR153","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.7150\/ijbs.85236","volume":"19","author":"Y Cai","year":"2023","unstructured":"Cai Y, Chen X, Lu T, Fang X, Ding M, Yu Z, et al. Activation of STING by SAMHD1 deficiency promotes PANoptosis and enhances efficacy of PD-L1 blockade in Diffuse Large B-cell Lymphoma. Int J Biol Sci. 2023;19:4627\u201343.","journal-title":"Int J Biol Sci"},{"key":"4514_CR154","doi-asserted-by":"publisher","unstructured":"Wang Z, Yang Y, Yao F-t, Zhang F, Lin K-y, Diao H-t, Zhao Q-y, Kong X, Si W, Xie Y-t et al. KLX ameliorates liver cancer progression by mediating ZBP1 transcription and ubiquitination and increasing ZBP1-induced PANoptosis. Acta Pharmacol Sin. 2025;46(8):2282\u20132295. https:\/\/doi.org\/10.1038\/s41401-025-01528-4","DOI":"10.1038\/s41401-025-01528-4"},{"key":"4514_CR155","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00262-025-04150-9","volume":"74","author":"J Wu","year":"2025","unstructured":"Wu J, Deng Y, Gao Y, Wei B. Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity. Cancer Immunol Immunother. 2025;74:293.","journal-title":"Cancer Immunol Immunother"},{"key":"4514_CR156","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41419-025-07835-2","volume":"16","author":"J Chen","year":"2025","unstructured":"Chen J, Ren J, Zhang C, Lv Y, Zhou J, Jiang W, Huang C, Cao L. Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe. Cell Death Dis. 2025;16:526.","journal-title":"Cell Death Dis"},{"key":"4514_CR157","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jare.2025.02.013","volume":"78","author":"W Yang","year":"2025","unstructured":"Yang W, Xu Y, Liu S, Gao L, Li S, Xie X, Zhang Q, Habib O, Chen R, Sun X, Li Z. Mebendazole induces ZBP-1 mediated PANoptosis of acute myeloid leukemia cells by targeting TUBA1A and exerts antileukemia effect. J Adv Res. 2025;78:487\u201396.","journal-title":"J Adv Res"},{"key":"4514_CR158","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1021\/acs.accounts.3c00309","volume":"56","author":"Y Tao","year":"2023","unstructured":"Tao Y, Jakobsson V, Chen X, Zhang J. Exploiting Albumin as a Versatile Carrier for Cancer Theranostics. Acc Chem Res. 2023;56:2403\u201315.","journal-title":"Acc Chem Res"},{"key":"4514_CR159","doi-asserted-by":"publisher","first-page":"2500880","DOI":"10.1002\/smll.202500880","volume":"21","author":"W Zhen","year":"2025","unstructured":"Zhen W, Zhao T, Chen X, Zhang J. Unlocking the Potential of Disulfidptosis: Nanotechnology-Driven Strategies for Advanced Cancer Therapy. Small. 2025;21:2500880.","journal-title":"Small"},{"key":"4514_CR160","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1039\/D2CS00757F","volume":"52","author":"K Peng","year":"2023","unstructured":"Peng K, Zheng Y, Xia W, Mao Z-W. Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses. Chem Soc Rev. 2023;52:2790\u2013832.","journal-title":"Chem Soc Rev"},{"key":"4514_CR161","doi-asserted-by":"publisher","first-page":"2410957","DOI":"10.1002\/adma.202410957","volume":"37","author":"X-K Jin","year":"2025","unstructured":"Jin X-K, Zhang S-K, Zhang S-M, Liang J-L, Yan X, Lin Y-T, Meng R, Xu Z-H, Liu C-J, Zhang X-Z. Disrupting Intracellular Homeostasis by Copper-Based Nanoinducer with Multiple Enzyme-Mimicking Activities to Induce Disulfidptosis-Enhanced Pyroptosis for Tumor Immunotherapy. Adv Mater. 2025;37:2410957.","journal-title":"Adv Mater"},{"key":"4514_CR162","doi-asserted-by":"publisher","first-page":"123359","DOI":"10.1016\/j.biomaterials.2025.123359","volume":"322","author":"K Zhang","year":"2025","unstructured":"Zhang K, Huang C, Ren Y, Zhang M, Lu X, Yang B, Chen P, Guo S, Wang X, Zhuo Y, et al. Manganese-based nanoadjuvants for the synergistic enhancement of immune responses in breast cancer therapy via disulfidptosis-induced ICD and cGAS-STING activation. Biomaterials. 2025;322:123359.","journal-title":"Biomaterials"},{"key":"4514_CR163","doi-asserted-by":"publisher","first-page":"138404","DOI":"10.1016\/j.jcis.2025.138404","volume":"700","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhang S, Hu X, Hu C, Lv Y, Pei Y, Ma K, Pei Z. Oxygen-driven Prussian blue nanomotor promotes cancer immunotherapy by disrupting redox state-induced tumor disulfide death. J Colloid Interface Sci. 2025;700:138404.","journal-title":"J Colloid Interface Sci"},{"key":"4514_CR164","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1038\/s41467-025-60015-w","volume":"16","author":"W Yu","year":"2025","unstructured":"Yu W, Jin D, Zhang Y, Wang S, Yu J, Liu M, Dai Y, Yin Y, Cheng J, Liu Y. Provoking tumor disulfidptosis by single-atom nanozyme via regulating cellular energy supply and reducing power. Nat Commun. 2025;16:4877.","journal-title":"Nat Commun"},{"key":"4514_CR165","doi-asserted-by":"publisher","first-page":"e06138","DOI":"10.1002\/smll.202506138","volume":"21","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li X-Q, Gao H, Yu Q, Long Y, Kang B, Zhao X, Xu J-J. Disulfidptosis and Enzymatic-Therapy Augmented Cuproptosis via Adding Spear and Discarding Shield Strategy. Small. 2025;21:e06138.","journal-title":"Small"},{"key":"4514_CR166","doi-asserted-by":"publisher","first-page":"35304","DOI":"10.1021\/acsami.5c07590","volume":"17","author":"X Hu","year":"2025","unstructured":"Hu X, Guo H, Wang G, Liao X, Zhang S. Poly(sodium lipoate) Particles with Nitroimidazole Modification for Disulfide Stress-Mediated Antitumor Metastasis. ACS Appl Mater Interfaces. 2025;17:35304\u201315.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4514_CR167","doi-asserted-by":"publisher","first-page":"14233","DOI":"10.1021\/acsnano.5c00730","volume":"19","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zheng H, Zhu X, Liu S, Jin H, Chen Y, Wan L, Zhang S, Zhang H. Synchronously Evoking Disulfidptosis and Ferroptosis via Systematical Glucose Deprivation Targeting SLC7A11\/GSH\/GPX4 Antioxidant Axis. ACS Nano. 2025;19:14233\u201348.","journal-title":"ACS Nano"},{"key":"4514_CR168","doi-asserted-by":"publisher","first-page":"157409","DOI":"10.1016\/j.cej.2024.157409","volume":"500","author":"T Su","year":"2024","unstructured":"Su T, Wu G, Zhou P, Wang J, Zhu X, Fan L, Yan H, Ma G, Liu Z, Wang X, Gao F. Resource-Conserving engineered nanoparticles Mediate disulfidptosis by overcoming resistance to ferroptosis for antitumor immunotherapy. Chem Eng J. 2024;500:157409.","journal-title":"Chem Eng J"},{"key":"4514_CR169","doi-asserted-by":"publisher","first-page":"137611","DOI":"10.1016\/j.jcis.2025.137611","volume":"693","author":"Q-M Zhou","year":"2025","unstructured":"Zhou Q-M, Lu Y-F, Yang X-Y, Zhang J-G, Wang Y-N, Luo W-P, Mao J, Hou J, Wu F, Wang W-L, et al. Redox-driven hybrid nanoenzyme dynamically activating ferroptosis and disulfidptosis for hepatocellular carcinoma theranostics. J Colloid Interface Sci. 2025;693:137611.","journal-title":"J Colloid Interface Sci"},{"key":"4514_CR170","doi-asserted-by":"publisher","first-page":"2309842","DOI":"10.1002\/smll.202309842","volume":"20","author":"S Guo","year":"2024","unstructured":"Guo S, Li Z, Zhou R, Feng J, Huang L, Ren B, Zhu J, Huang Y, Wu G, Cai H, et al. MRI-Guided Tumor Therapy Based on Synergy of Ferroptosis, Immunosuppression Reversal and Disulfidptosis. Small. 2024;20:2309842.","journal-title":"Small"},{"key":"4514_CR171","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.cmet.2024.06.014","volume":"36","author":"C Vernieri","year":"2024","unstructured":"Vernieri C, Ligorio F, Tripathy D, Longo VD. Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence. Cell Metabol. 2024;36:1644\u201367.","journal-title":"Cell Metabol"},{"key":"4514_CR172","doi-asserted-by":"publisher","first-page":"e2304791","DOI":"10.1002\/advs.202304791","volume":"11","author":"T Wang","year":"2024","unstructured":"Wang T, Zhang Y, Liu Y, Huang Y, Wang W. Amino Acid-Starved Cancer Cells Utilize Macropinocytosis and Ubiquitin-Proteasome System for Nutrient Acquisition. Adv Sci (Weinh). 2024;11:e2304791.","journal-title":"Adv Sci (Weinh)"},{"key":"4514_CR173","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, Byun J-K, Choi Y-K, Park K-G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55:706\u201315.","journal-title":"Exp Mol Med"},{"key":"4514_CR174","doi-asserted-by":"publisher","first-page":"113739","DOI":"10.1016\/j.jconrel.2025.113739","volume":"383","author":"Y Li","year":"2025","unstructured":"Li Y, Lu Y, Lu W, Zhong N, Li N, Xu Z, Zhang J, Sun H, Wu F, Teng Z, et al. Transformable albumin-based nanocapsules selectively amplify tumor starvation and disulfidptosis through metabolic deception. J Controlled Release. 2025;383:113739.","journal-title":"J Controlled Release"},{"key":"4514_CR175","doi-asserted-by":"publisher","first-page":"159871","DOI":"10.1016\/j.cej.2025.159871","volume":"505","author":"T Huo","year":"2025","unstructured":"Huo T, Zhu B, Shan X, Song J, Wang Z, Zhou J, Zhang X, Bai Y, Liu C, Zhao Y, et al. Allicin amplifies disulfidptosis during GOx catalyzing glucose-starvation for cancer therapy via simultaneous antimicrobial and antitumor intervention. Chem Eng J. 2025;505:159871.","journal-title":"Chem Eng J"},{"key":"4514_CR176","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-021-01952-4","volume":"40","author":"F Tan","year":"2021","unstructured":"Tan F, Zhao M, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, et al. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. J Experimental Clin Cancer Res. 2021;40:146.","journal-title":"J Experimental Clin Cancer Res"},{"key":"4514_CR177","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13059-021-02271-9","volume":"22","author":"V Tassinari","year":"2021","unstructured":"Tassinari V, Cesarini V, Tomaselli S, Ianniello Z, Silvestris DA, Ginistrelli LC, Martini M, De Angelis B, De Luca G, Vitiani LR, et al. ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism. Genome Biol. 2021;22:51.","journal-title":"Genome Biol"},{"key":"4514_CR178","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19:106.","journal-title":"Mol Cancer"},{"key":"4514_CR179","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","volume":"38","author":"W Peng","year":"2019","unstructured":"Peng W, Li J, Chen R, Gu Q, Yang P, Qian W, et al. Upregulated METTL3 promotes metastasis of colorectal cancer via miR-1246\/SPRED2\/MAPK signaling pathway. J Exp Clin Cancer Res. 2019;38:393.","journal-title":"J Exp Clin Cancer Res"},{"key":"4514_CR180","doi-asserted-by":"publisher","first-page":"123168","DOI":"10.1016\/j.biomaterials.2025.123168","volume":"319","author":"H Tian","year":"2025","unstructured":"Tian H, Deng H, Liu X, Liu C, Zhang C, Leong KW, Fan X, Ruan J. A novel FTO-targeting nanodrug induces disulfidptosis and ameliorates the suppressive tumor immune environment to treat uveal melanoma. Biomaterials. 2025;319:123168.","journal-title":"Biomaterials"},{"key":"4514_CR181","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380\u201393.","journal-title":"J Pathol"},{"key":"4514_CR182","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533\u201348.","journal-title":"Nat Rev Cancer"},{"key":"4514_CR183","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ccell.2018.11.016","volume":"35","author":"M Shen","year":"2019","unstructured":"Shen M, Jiang Y-Z, Wei Y, Ell B, Sheng X, Esposito M, Kang J, Hang X, Zheng H, Rowicki M, et al. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin\/FAK and EGFR Signaling. Cancer Cell. 2019;35:64\u2013e8067.","journal-title":"Cancer Cell"},{"key":"4514_CR184","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1038\/s41467-018-05850-w","volume":"9","author":"F Haun","year":"2018","unstructured":"Haun F, Neumann S, Peintner L, Wieland K, Habicht J, Schwan C, \u00d8stevold K, Koczorowska MM, Biniossek M, Kist M, et al. Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin. Nat Commun. 2018;9:3524.","journal-title":"Nat Commun"},{"key":"4514_CR185","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","volume":"11","author":"O Saatci","year":"2020","unstructured":"Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, Sikirzhytski V, Tokat UM, Aykut G, Ansari SA, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020;11:2416.","journal-title":"Nat Commun"},{"key":"4514_CR186","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.03.011","volume":"508","author":"H-j Han","year":"2021","unstructured":"Han H-j, Sung JY, Kim S-H, Yun U-J, Kim H, Jang E-J, Yoo H-E, Hong EK, Goh S-H, Moon A, et al. Fibronectin regulates anoikis resistance via cell aggregate formation. Cancer Lett. 2021;508:59\u201372.","journal-title":"Cancer Lett"},{"key":"4514_CR187","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41392-019-0104-3","volume":"5","author":"Z Gong","year":"2020","unstructured":"Gong Z, Chen M, Ren Q, Yue X, Dai Z. Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Therapy. 2020;5:12.","journal-title":"Signal Transduct Target Therapy"},{"key":"4514_CR188","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/humupd\/dmx032","volume":"24","author":"MS Islam","year":"2018","unstructured":"Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24:59\u201385.","journal-title":"Hum Reprod Update"},{"key":"4514_CR189","doi-asserted-by":"publisher","first-page":"2203518","DOI":"10.1002\/adma.202203518","volume":"34","author":"L Wang","year":"2022","unstructured":"Wang L, Li C, Wang J, Yang G, Lv Y, Fu B, Jian L, Ma J, Yu J, Yang Z, et al. Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity. Adv Mater. 2022;34:2203518.","journal-title":"Adv Mater"},{"key":"4514_CR190","doi-asserted-by":"publisher","unstructured":"Covarrubias AA, Reyna-Jeldes M, Pedroso-Santana S, Mar\u00edn S, Madero-Mendoza C, Demergasso C, Coddou C. Arsenic Nanoparticles Trigger Apoptosis via Anoikis Induction in OECM-1 Cells. Int J Mol Sci. 2024;25(12):6723. https:\/\/doi.org\/10.3390\/ijms25126723","DOI":"10.3390\/ijms25126723"},{"key":"4514_CR191","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445\u201355.","journal-title":"Nature"},{"key":"4514_CR192","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.ccell.2021.09.004","volume":"39","author":"C Palena","year":"2021","unstructured":"Palena C, Gulley JL. A rare insight into the immunosuppressive landscape of prostate cancer bone metastases. Cancer Cell. 2021;39:1450\u20132.","journal-title":"Cancer Cell"},{"key":"4514_CR193","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13073-022-01079-x","volume":"14","author":"M Yang","year":"2022","unstructured":"Yang M, Lin C, Wang Y, Chen K, Zhang H, Li W. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance. Genome Med. 2022;14:72.","journal-title":"Genome Med"},{"key":"4514_CR194","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, Diaz LA. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Reviews Gastroenterol Hepatol. 2019;16:361\u201375.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"4514_CR195","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1021\/acsnano.1c11132","volume":"16","author":"H Lin","year":"2022","unstructured":"Lin H, Yang C, Luo Y, Ge M, Shen H, Zhang X, et al. Biomimetic nanomedicine-triggered in situ vaccination for innate and adaptive immunity activations for bacterial osteomyelitis treatment. ACS Nano. 2022;16:5943\u201360.","journal-title":"ACS Nano"},{"key":"4514_CR196","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","volume":"22","author":"EC Morris","year":"2022","unstructured":"Morris EC, Neelapu SS, Giavridis T, Sadelain M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat Rev Immunol. 2022;22:85\u201396.","journal-title":"Nat Rev Immunol"},{"key":"4514_CR197","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1158\/2159-8290.CD-20-1661","volume":"11","author":"D Alizadeh","year":"2021","unstructured":"Alizadeh D, Wong RA, Gholamin S, Maker M, Aftabizadeh M, Yang X, Pecoraro JR, Jeppson JD, Wang D, Aguilar B, et al. IFN\u03b3 Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity. Cancer Discov. 2021;11:2248\u201365.","journal-title":"Cancer Discov"},{"key":"4514_CR198","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","volume":"12","author":"A Rodriguez-Garcia","year":"2021","unstructured":"Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O\u2019Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T, Powell DJ. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy. Nat Commun. 2021;12:877.","journal-title":"Nat Commun"},{"key":"4514_CR199","doi-asserted-by":"publisher","first-page":"e2309988","DOI":"10.1002\/advs.202309988","volume":"11","author":"W Li","year":"2024","unstructured":"Li W, Huang M, Wu Z, Zhang Y, Cai Y, Su J, Xia J, Yang F, Xiao D, Yang W, et al. mRNA-Lipid Nanoparticle-Mediated Restoration of PTPN14 Exhibits Antitumor Effects by Overcoming Anoikis Resistance in Triple-Negative Breast Cancer. Adv Sci (Weinh). 2024;11:e2309988.","journal-title":"Adv Sci (Weinh)"},{"key":"4514_CR200","doi-asserted-by":"publisher","first-page":"2400673","DOI":"10.1002\/adhm.202400673","volume":"13","author":"B Dong","year":"2024","unstructured":"Dong B, Gu Y, Sun X, Wang X, Zhou Y, Rong Z, Zhang J, Shi X, Zhang Z, He X, et al. Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer. Adv Healthc Mater. 2024;13:2400673.","journal-title":"Adv Healthc Mater"},{"key":"4514_CR201","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1038\/ncomms8351","volume":"6","author":"B Aslan","year":"2015","unstructured":"Aslan B, Monroig P, Hsu M-C, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han H-D, et al. The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun. 2015;6:7351.","journal-title":"Nat Commun"},{"key":"4514_CR202","doi-asserted-by":"publisher","first-page":"103514","DOI":"10.1016\/j.redox.2025.103514","volume":"80","author":"G Matrullo","year":"2025","unstructured":"Matrullo G, Filomeni G, Rizza S. Redox regulation of focal adhesions. Redox Biol. 2025;80:103514.","journal-title":"Redox Biol"},{"key":"4514_CR203","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12951-024-02739-3","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ding L, Chen G, Wang P, Wang X. A thermo-sensitive hydrogel with prominent hemostatic effect prevents tumor recurrence via anti-anoikis-resistance. J Nanobiotechnol. 2024;22:496.","journal-title":"J Nanobiotechnol"},{"key":"4514_CR204","doi-asserted-by":"publisher","unstructured":"Shen Y, Chen Q-C, Li C-Y, Han F-J. Independent organelle and organelle\u2014organelle interactions: essential mechanisms for malignant gynecological cancer cell survival. Front Immunol. 2024;15:1393852. https:\/\/doi.org\/10.3389\/fimmu.2024.1393852","DOI":"10.3389\/fimmu.2024.1393852"},{"key":"4514_CR205","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.scib.2025.02.034","volume":"70","author":"H Qi","year":"2025","unstructured":"Qi H, Li X, Ma J, Sun J, Liu Y, Wang X, Fan K, Shu C, Wang C. Fullerenols hijack lysosomes to disrupt inter-organellar crosstalk and block autophagy pre-activated by mTOR inhibitors for cancer cell PANoptosis. Sci Bull. 2025;70:1275\u201394.","journal-title":"Sci Bull"},{"key":"4514_CR206","doi-asserted-by":"crossref","unstructured":"Lin Y, Zhang H, Liang J, Li K, Zhu W, Fu L, Wang F, Zheng X, Shi H, Wu S et al. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. Proceedings of the National Academy of Sciences 2014, 111:E4504-E4512.","DOI":"10.1073\/pnas.1408759111"},{"key":"4514_CR207","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41467-024-48032-7","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Song A, Xie J, Wang Y-Y, Wang W-D, Zhang M-J, Wu Z-Z, Yang Q-C, Li H, Zhang J, Sun Z-J. Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity. Nat Commun. 2024;15:3669.","journal-title":"Nat Commun"},{"key":"4514_CR208","doi-asserted-by":"crossref","unstructured":"Wang C, Zhang R, Wei X, Lv M, Jiang Z. Chapter Seven - Metalloimmunology: The metal ion-controlled immunity. In: Dong C, Jiang Z, editors. Advances in Immunology., vol. 145. Academic Press; 2020. p. 187\u2013241.","DOI":"10.1016\/bs.ai.2019.11.007"},{"key":"4514_CR209","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp7160","volume":"10","author":"G Hou","year":"2024","unstructured":"Hou G, Chen Y, Lei H, Lu Y, Liu L, Han Z, et al. Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis for enhanced immunotherapy. Sci Adv. 2024;10(45):eadp7160. https:\/\/doi.org\/10.1126\/sciadv.adp7160","journal-title":"Sci Adv"},{"key":"4514_CR210","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","volume":"29","author":"B Li","year":"2022","unstructured":"Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Delivery. 2022;29:2130\u201361.","journal-title":"Drug Delivery"},{"key":"4514_CR211","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27238295","author":"S Pramual","year":"2022","unstructured":"Pramual S, Lirdprapamongkol K, Atjanasuppat K, Chaisuriya P, Niamsiri N, Svasti J. PLGA-Lipid hybrid nanoparticles for overcoming Paclitaxel tolerance in anoikis-resistant lung cancer cells. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27238295.","journal-title":"Molecules"},{"key":"4514_CR212","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/10717544.2021.1898703","volume":"28","author":"M Song","year":"2021","unstructured":"Song M, Xia W, Tao Z, Zhu B, Zhang W, Liu C, et al. Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy. Drug Deliv. 2021;28:594\u2013606.","journal-title":"Drug Deliv"},{"key":"4514_CR213","doi-asserted-by":"publisher","first-page":"1902246","DOI":"10.1002\/adfm.201902246","volume":"29","author":"X-g Han","year":"2019","unstructured":"Han X-g, Yang S-b, Mo H-m, Wang M-q, Zhou F, Li H-j, Qiao H, Mei J-t, Wang Y-j, Cheng Y-w, et al. Targeting of CXCR1 on Osteosarcoma Circulating Tumor Cells and Precise Treatment via Cisplatin Nanodelivery. Adv Funct Mater. 2019;29:1902246.","journal-title":"Adv Funct Mater"},{"key":"4514_CR214","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","volume":"39","author":"H Wang","year":"2018","unstructured":"Wang H, Mu X, He H, Zhang X-D. Cancer radiosensitizers. Trends Pharmacol Sci. 2018;39:24\u201348.","journal-title":"Trends Pharmacol Sci"},{"key":"4514_CR215","doi-asserted-by":"publisher","first-page":"2206370","DOI":"10.1002\/adma.202206370","volume":"35","author":"W Zhen","year":"2023","unstructured":"Zhen W, Weichselbaum RR, Lin W. Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy. Adv Mater. 2023;35:2206370.","journal-title":"Adv Mater"},{"key":"4514_CR216","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202413002","volume":"n\/a","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang S, Yang Q-C, Song A, Wang Y-Y, Wang W-D, et al. Radioactive diselenide bonded covalent organic framework. Adv Mater. 2025;n\/a:2413002.","journal-title":"Adv Mater"},{"key":"4514_CR217","volume":"n\/a","author":"W Zhen","year":"2024","unstructured":"Zhen W, Fan Y, Germanas T, Tillman L, Li J, Blenko AL, et al. Digitonin-loaded nanoscale metal\u2013organic framework for mitochondria-targeted radiotherapy-radiodynamic therapy and Disulfidptosis. Adv Mater. 2024;n\/a:2405494.","journal-title":"Adv Mater"},{"key":"4514_CR218","doi-asserted-by":"publisher","first-page":"123178","DOI":"10.1016\/j.biomaterials.2025.123178","volume":"319","author":"K Wang","year":"2025","unstructured":"Wang K, Li L, Liang G, Xiao H, Zhang L, Liu T. Sonodynamic activated nanoparticles with Glut1 inhibitor and cystine-containing polymer stimulate disulfidptosis for improved immunotherapy in bladder cancer. Biomaterials. 2025;319:123178.","journal-title":"Biomaterials"},{"key":"4514_CR219","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.7150\/thno.115275","volume":"15","author":"K Yun","year":"2025","unstructured":"Yun K, Yu X, Liang S, Wang Q, Zhang Z, Han Y, Zhao Y, Peng Y, Rao L, Cui Y, Wang Z. Tumor-responsive cuproptosis nanoinducer realizing efficient PANoptosis for enhanced cancer immunotherapy. Theranostics. 2025;15:9294\u2013305.","journal-title":"Theranostics"},{"key":"4514_CR220","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1039\/C8CS00618K","volume":"48","author":"Y Liu","year":"2019","unstructured":"Liu Y, Bhattarai P, Dai Z, Chen X. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2019;48:2053\u2013108.","journal-title":"Chem Soc Rev"},{"key":"4514_CR221","doi-asserted-by":"publisher","first-page":"2500272","DOI":"10.1002\/adhm.202500272","volume":"14","author":"A Mohanty","year":"2025","unstructured":"Mohanty A, Mohapatra A, Yang W, Choi S, Sundaram A, Jeong Y-Y, Lee C-M, Seo J, Park I-K. Programable Prodrug Nanomodulator Targets Tumor Redox Homeostasis Imbalance to Amplify Disulfidptosis and Immunogenic Pyroptosis for Breast Tumor Immunotherapy. Adv Healthc Mater. 2025;14:2500272.","journal-title":"Adv Healthc Mater"},{"key":"4514_CR222","doi-asserted-by":"publisher","first-page":"213859","DOI":"10.1016\/j.bioadv.2024.213859","volume":"160","author":"T Zhang","year":"2024","unstructured":"Zhang T, Wang X, Wang D, Lei M, Hu Y, Chen Z, Li Y, Luo Y, Zhang L, Zhu Y. Synergistic effects of photodynamic therapy and chemotherapy: Activating the intrinsic\/extrinsic apoptotic pathway of anoikis for triple-negative breast cancer treatment. Biomaterials Adv. 2024;160:213859.","journal-title":"Biomaterials Adv"},{"key":"4514_CR223","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.biomaterials.2018.04.045","volume":"173","author":"D Zhang","year":"2018","unstructured":"Zhang D, Feng F, Li Q, Wang X, Yao L. Nanopurpurin-based photodynamic therapy destructs extracellular matrix against intractable tumor metastasis. Biomaterials. 2018;173:22\u201333.","journal-title":"Biomaterials"},{"key":"4514_CR224","doi-asserted-by":"publisher","unstructured":"Ma C, Gao L, Song K, Gu B, Wang B, Yu Y, et al. Targeted dual-responsive liposomes co-deliver Jolkinolide B and Ce6 to synergistically enhance the photodynamic\/immunotherapy efficacy in gastric cancer through the PANoptosis pathway. Adv Sci (Weinh). 2025;12(29):e02289. https:\/\/doi.org\/10.1002\/advs.202502289","DOI":"10.1002\/advs.202502289"},{"key":"4514_CR225","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1038\/s41467-024-53135-2","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Wang X, Feng L, Zhao R, Yu C, Liu Y, Xie Y, Liu B, Zhou Y, Yang P. Intermetallics triggering pyroptosis and disulfidptosis in cancer cells promote anti-tumor immunity. Nat Commun. 2024;15:8696.","journal-title":"Nat Commun"},{"key":"4514_CR226","doi-asserted-by":"publisher","first-page":"e723","DOI":"10.1002\/agt2.723","volume":"6","author":"J Lin","year":"2025","unstructured":"Lin J, Cai X, Zou F, Xie W, Zou Z, Chen M, Zhang Y, He H, Xu Q, Zhong G, et al. Fluorescent Nanoparticles Achieve Efficient Photothermal Conversion and Enhanced Antitumor Efficacy Through Intermolecular Aggregation-Caused Quenching. Aggregate. 2025;6:e723.","journal-title":"Aggregate"},{"key":"4514_CR227","doi-asserted-by":"publisher","first-page":"110314","DOI":"10.1016\/j.cclet.2024.110314","volume":"36","author":"S Zhang","year":"2025","unstructured":"Zhang S, Li J, Hu X, Chen Z, Dong J, Hu C, Chao S, Lv Y, Pei Y, Pei Z. H2S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis. Chin Chem Lett. 2025;36:110314.","journal-title":"Chin Chem Lett"},{"key":"4514_CR228","doi-asserted-by":"publisher","first-page":"1805875","DOI":"10.1002\/adma.201805875","volume":"31","author":"Q Fu","year":"2019","unstructured":"Fu Q, Zhu R, Song J, Yang H, Chen X. Photoacoustic Imaging: Contrast Agents and Their Biomedical Applications. Adv Mater. 2019;31:1805875.","journal-title":"Adv Mater"},{"key":"4514_CR229","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.7150\/thno.25131","volume":"8","author":"H Lee","year":"2018","unstructured":"Lee H, Jang Y, Park S, Jang H, Park E-J, Kim HJ, Kim H. Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer. Theranostics. 2018;8:4247\u201361.","journal-title":"Theranostics"},{"key":"4514_CR230","doi-asserted-by":"publisher","first-page":"2003214","DOI":"10.1002\/adma.202003214","volume":"32","author":"S Liang","year":"2020","unstructured":"Liang S, Deng X, Ma Pa, Cheng Z, Lin J. Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy. Adv Mater. 2020;32:2003214.","journal-title":"Adv Mater"},{"key":"4514_CR231","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1039\/C9CS00648F","volume":"49","author":"S Son","year":"2020","unstructured":"Son S, Kim JH, Wang X, Zhang C, Yoon SA, Shin J, Sharma A, Lee MH, Cheng L, Wu J, Kim JS. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev. 2020;49:3244\u201361.","journal-title":"Chem Soc Rev"},{"key":"4514_CR232","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1021\/acs.bioconjchem.0c00029","volume":"31","author":"V Choi","year":"2020","unstructured":"Choi V, Rajora MA, Zheng G. Activating Drugs with Sound: Mechanisms Behind Sonodynamic Therapy and the Role of Nanomedicine. Bioconjug Chem. 2020;31:967\u201389.","journal-title":"Bioconjug Chem"},{"key":"4514_CR233","doi-asserted-by":"publisher","first-page":"2211130","DOI":"10.1002\/adma.202211130","volume":"35","author":"S Liang","year":"2023","unstructured":"Liang S, Yao J, Liu D, Rao L, Chen X, Wang Z. Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy. Adv Mater. 2023;35:2211130.","journal-title":"Adv Mater"},{"key":"4514_CR234","doi-asserted-by":"publisher","first-page":"30303","DOI":"10.1021\/acsnano.5c08432","volume":"19","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ming X, Qi J, Huang Z, Zhu H, Wu M, et al. Disulfidptosis nanoinducer interrupts tumor metabolic privilege to boost sustained immunotherapy. ACS Nano. 2025;19:30303\u201321.","journal-title":"ACS Nano"},{"key":"4514_CR235","doi-asserted-by":"publisher","first-page":"107368","DOI":"10.1016\/j.ultsonch.2025.107368","volume":"118","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lin X, Qiu J, Sun Y, Wu B, Shang H, Deng L, Wang X, Li N, Huang C, et al. Ultrasound-responsive nanobubble-mediated sonodynamic therapy sensitizes disulfidptosis in the treatment of liver hepatocellular carcinoma. Ultrason Sonochem. 2025;118:107368.","journal-title":"Ultrason Sonochem"},{"key":"4514_CR236","doi-asserted-by":"publisher","first-page":"122962","DOI":"10.1016\/j.biomaterials.2024.122962","volume":"315","author":"Z He","year":"2025","unstructured":"He Z, Wang Q, Du J, Wu S, Miao Q, Li Y, Miao Y, Wu J. Overcoming tumor hypoxic bismuth-based ternary heterojunctions enable defect modulation-augmented tumor sonocatalytic immunotherapy. Biomaterials. 2025;315:122962.","journal-title":"Biomaterials"},{"key":"4514_CR237","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1038\/s41467-024-50769-0","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhang Y, Zhang Y, Li H, Ou M, Yu Y, Zhang F, Yin H, Mao Z, Mei L. Catalytic activity of violet phosphorus-based nanosystems and the role of metabolites in tumor therapy. Nat Commun. 2024;15:6783.","journal-title":"Nat Commun"},{"key":"4514_CR238","doi-asserted-by":"publisher","first-page":"2107820","DOI":"10.1002\/adma.202107820","volume":"34","author":"T Zhang","year":"2022","unstructured":"Zhang T, Tian T, Lin Y. Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application. Adv Mater. 2022;34:2107820.","journal-title":"Adv Mater"},{"key":"4514_CR239","doi-asserted-by":"publisher","first-page":"2500406","DOI":"10.1002\/advs.202500406","volume":"12","author":"L Zhong","year":"2025","unstructured":"Zhong L, Guo X, Deng L, Wang X, He H, Wu N, Tang R, Chen L, Chen Y, Li P. Dopant-Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy. Adv Sci. 2025;12:2500406.","journal-title":"Adv Sci"},{"key":"4514_CR240","doi-asserted-by":"publisher","first-page":"2305361","DOI":"10.1002\/adma.202305361","volume":"36","author":"L Zhou","year":"2024","unstructured":"Zhou L, Lyu J, Liu F, Su Y, Feng L, Zhang X. Immunogenic PANoptosis-Initiated Cancer Sono-Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle. Adv Mater. 2024;36:2305361.","journal-title":"Adv Mater"},{"key":"4514_CR241","doi-asserted-by":"publisher","first-page":"123523","DOI":"10.1016\/j.biomaterials.2025.123523","volume":"324","author":"Z Wang","year":"2026","unstructured":"Wang Z, Li Y, Wang C, Lan J, Li J, Liu G, Chen Y, Yu D, Liu Z, Gao F. Disrupting intracellular redox homeostasis through copper-driven dual cell death to induce anti-tumor immunotherapy. Biomaterials. 2026;324:123523.","journal-title":"Biomaterials"},{"key":"4514_CR242","doi-asserted-by":"publisher","first-page":"123592","DOI":"10.1016\/j.biomaterials.2025.123592","volume":"325","author":"Z Wu","year":"2026","unstructured":"Wu Z, Gao M, Li Q, Lan H, Zheng Y, Zheng S, Hou M, Xu Y, Shen Z, Zhao B, Yan C. Copper metal-organic framework-based multifaceted strategy for boosting cancer therapy via synergistic cuproptosis and disulfidptosis. Biomaterials. 2026;325:123592.","journal-title":"Biomaterials"},{"key":"4514_CR243","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.2147\/IJN.S464178","volume":"19","author":"H Xiang","year":"2024","unstructured":"Xiang H, Shen B, Zhang C, Li R. Bioactive Nanoliposomes for Enhanced Sonodynamic-Triggered Disulfidptosis-Like Cancer Cell Death via Lipid Peroxidation. Int J Nanomed. 2024;19:8929\u201347.","journal-title":"Int J Nanomed"},{"key":"4514_CR244","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.7150\/thno.111635","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chai C, Lin W, Cao J, Li Z, Jin Y, Xu Y, Zhang J, Qu Y, Zhan J, et al. Oxidative stress-mediated PANoptosis and ferroptosis: Exploration of multimodal cell death triggered by an AIE-active nano-photosensitizer via photodynamic therapy. Theranostics. 2025;15:6665\u201385.","journal-title":"Theranostics"},{"key":"4514_CR245","doi-asserted-by":"publisher","first-page":"102312","DOI":"10.1016\/j.xcrm.2025.102312","volume":"6","author":"H Huang","year":"2025","unstructured":"Huang H, Xiao Z, Feng W, Song X, Chen L, Huang L, Ding L, Chen Y. Biomimetic nanoimmunotherapy boosts spatiotemporal PANoptosis and reshapes desmoplastic tumor microenvironment. Cell Rep Med. 2025;6:102312.","journal-title":"Cell Rep Med"},{"key":"4514_CR246","doi-asserted-by":"publisher","first-page":"163961","DOI":"10.1016\/j.cej.2025.163961","volume":"516","author":"Z He","year":"2025","unstructured":"He Z, Li Y, Feng Q, Li Y, Ding J, Ye L, Ji J, Yang X, Zhai G. A cerium-based ferroptosis\/PANoptosis nano-inducer for photothermal-enhanced combination therapy of breast cancer. Chem Eng J. 2025;516:163961.","journal-title":"Chem Eng J"},{"key":"4514_CR247","doi-asserted-by":"publisher","first-page":"102270","DOI":"10.1016\/j.nantod.2024.102270","volume":"56","author":"X Xu","year":"2024","unstructured":"Xu X, Shabiti S, Zhang X, Zheng J, Liang N, Wang Z, Yu S, Wang Y, Jiang S, Pan Z, et al. Membrane-anchoring clickable Iridium(III) nanosonosensitizer in situ evokes PANoptosis for augmented tumor sono-immunotherapy. Nano Today. 2024;56:102270.","journal-title":"Nano Today"},{"key":"4514_CR248","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/idm2.12240","volume":"4","author":"T Xu","year":"2025","unstructured":"Xu T, Song X, Chang M, Chen L, Xia L, Chen Y, Guo Q. Dual Vacancies-Engineered Two-Dimensional Sonocatalysts for Ultrasound-Augmented and PANoptosis-Driven Catalytic Tumor Nanotherapy. Interdisciplinary Mater. 2025;4:343\u201358.","journal-title":"Interdisciplinary Mater"},{"key":"4514_CR249","doi-asserted-by":"publisher","first-page":"163201","DOI":"10.1016\/j.cej.2025.163201","volume":"514","author":"C Zhang","year":"2025","unstructured":"Zhang C, Chen Y, Yu Z, Qi Y, Xia J, Zheng H, Hu K, Rao W, Zhou T. Autologous nanovaccine repolarizes tumor-associated macrophages to M1 phenotype inducing PANoptosis for lung cancer immunotherapy. Chem Eng J. 2025;514:163201.","journal-title":"Chem Eng J"},{"key":"4514_CR250","doi-asserted-by":"publisher","first-page":"147056","DOI":"10.1016\/j.cej.2023.147056","volume":"477","author":"R Zhang","year":"2023","unstructured":"Zhang R, Chen G, Du J, Wang Q, Qi Q, Li X, Zhu L, Chen X, Liu B, Miao Y, Li Y. Rare earth regulatory defect engineering: A multifunctional nanoplatform for breast cancer therapy through PANoptosis. Chem Eng J. 2023;477:147056.","journal-title":"Chem Eng J"},{"key":"4514_CR251","doi-asserted-by":"publisher","first-page":"161355","DOI":"10.1016\/j.cej.2025.161355","volume":"509","author":"X Lu","year":"2025","unstructured":"Lu X, Sun W, Zheng X, Yang L, Feng T, Deng X, Zhou F, Zhu H, Ma D, Li B, et al. Ruthenium-doped carbon dots with three-in-one chemodynamic, photodynamic, and photothermal activity induce panoptosis for tumor therapy. Chem Eng J. 2025;509:161355.","journal-title":"Chem Eng J"},{"key":"4514_CR252","doi-asserted-by":"publisher","first-page":"2409618","DOI":"10.1002\/adma.202409618","volume":"36","author":"W Wei","year":"2024","unstructured":"Wei W, Wang H, Ren C, Deng R, Qin Q, Ding L, Li P, Liu Y, Chang M, Chen Y, Zhou Y. Ultrasmall Enzyodynamic PANoptosis Nano-Inducers for Ultrasound-Amplified Hepatocellular Carcinoma Therapy and Lung Metastasis Inhibition. Adv Mater. 2024;36:2409618.","journal-title":"Adv Mater"},{"key":"4514_CR253","doi-asserted-by":"publisher","first-page":"2401697","DOI":"10.1002\/adhm.202401697","volume":"13","author":"S Wu","year":"2024","unstructured":"Wu S, Wang Q, Du J, Zhu L, Yang F, Lu J, Li X, Li Y, Cui J, Miao Y. Bi-Pt Heterojunction Cascade Reaction Platform for Sono-Immunotherapy of Tumors via PANoptosis and Ferroptosis. Adv Healthc Mater. 2024;13:2401697.","journal-title":"Adv Healthc Mater"},{"key":"4514_CR254","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12951-025-03381-3","volume":"23","author":"Y Ye","year":"2025","unstructured":"Ye Y, Zhao S, Pang E, Tang Y, Zhu P, Gao W, Diao Q, Yu J, Zeng J, Lan M, Yi J. Indacenodithienothiophene-based A-D-A-type phototheranostics for immuno-phototherapy. J Nanobiotechnol. 2025;23:309.","journal-title":"J Nanobiotechnol"},{"key":"4514_CR255","doi-asserted-by":"publisher","first-page":"e06349","DOI":"10.1002\/adma.202506349","volume":"37","author":"P Wang","year":"2025","unstructured":"Wang P, Yu L-B, Shen Q-H, Dao J, Di Z-Y, Li Z-Y, Zhang X-Y, Hu Q-Y, Tan C-P. Synergistic Copper-Coordination\/Glutathione Reduction Drives an In Situ Type II-to-Type I Photodynamic Switch in Iridium-Based Photosensitizer Nanocomposites for Potentiated Cancer Immunotherapy. Adv Mater. 2025;37:e06349.","journal-title":"Adv Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04514-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04514-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04514-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:02:46Z","timestamp":1787230966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04514-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":255,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4514"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04514-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"783"}}